Summary
Four patients with malignant gliomas recurring after surgical resection, radiotherapy and chemotherapy were entered into a trial of immunotherapy. Partial removal of the recurrent tumors was performed and autologous mononuclear cell infusions were given into the resection cavity via a subgaleal reservoir that had been inserted at the time of tumor resection. Mononuclear cells were obtained using a cell separator and Ficoll-hypaque separation techniques. Patients were followed carefully with clinical examinations, CT brain scans and immunological testing. All patients have died and complete autopsies were done. We looked specifically for evidence of mononuclear cell penetration into the tumor and possible adverse effects on the normal brain or in the rest of the body. The results indicate that this type of therapy can be performed safely and may be useful in the treatment of patients with malignant gliomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest 21 (suppl. 97):77–89, 1968.
Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J II, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 303:1323–1329, 1980.
Ridley A, Cavanagh JB: Lymphocytic infiltration in gliomas: Evidence of possible host resistance. Brain 94:117–124, 1971.
Schiffer D, Creveri G, Pautasso C: Frequenza e significato degli infiltrati linfo-plasma cellulari nei gliomi umani. Tumori 60:177–184, 1974.
Brooks WH, Markesberry MD, Gupta GF, Roszman TL: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978.
Dilorenzo N, Palma, L, Nicole S: Lymphocytic infiltration in long-survival glioblastomas: Possible host's resistance. Acta Neurochir 31:27–33, 1977.
Palma L, DiLorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. J Neurosurg 49:845–861, 1978.
Coakham HB, Lakshmi MS: Tumor-associate surface antigen(s) in human astrocytomas. Oncology 31:233–243, 1975.
Wahlstrom T, Linder E, Saksela E, Westermark B: Tumor-specific membrane antigens in established cell lines from gliomas. Cancer 34:1974–279, 1974.
Wikstrand CJ, Mahaley MS, Bigner DD: Surface antigenic characteristics of human glial brain tumor cells. Cancer Res 37:4267–4275, 1977.
Brooks WH, Caldwell HD, Mortara RH: Immune responses in patients with gliomas. Surg Neurol 2:419–423, 1974.
Kumar S, Taylor G, Steward JK, Waghe MA, Morris-Jones P: Cell mediated immunity to human brain tumors. Cancer Res 32:477–482, 1972.
Levy NL, Mahaley MS, Day ED: In vitro demonstration of cell mediated immunity to human brain tumors. Cancer Res 32:477–482, 1972.
Wahlstrom T, Saksela E, Troupp H: Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol 6:161–170, 1973.
Woosley RE, Mahaley MS, Mahaley JL, Miller GM, Brooks WH: Immunobiology of primary intracranial tumors. (Part 3) Microtoxicity assays of specific immune responses of brain tumor patients. J Neurosurg 47:871–885, 1977.
Young HE, Kaplan A: Immunotherapy of human gliomas. In: Waters H (ed) The handbook of cancer immunology. Garland STPM Press, New York and London, Volume 5, 1978, pp 357–382.
Brooks WH, Roszman TL, Mahaley MS, Woosley RE: Immunobiology of primary intracranial tumors: II. Analysis of lymphocyte subpopulations in patients with primary brain tumors. Clin Exp Immunol 24:6–64, 1977.
Mahaley MS, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S: Immunobiology of primary intracranial tumors: Part I studies of cellular and tumoral general immune competence of brain-tumor patients. J Neurosurg 46:467–476, 1977.
Roszman TL, Brooks WH: Immunobiology of primary intracranial tumors (III). Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumors. Clin Exp Immunol 39:395–402, 1980.
Medawar PB: Immunity of homologous grafted skin: (III) Fate of skin homografts transplanted to brain, to subcutaneous tissue and to anterior chamber of the eye. Brit J Exp Path 29:56–59, 1948.
Scheinberg LC, Edelman F, Levy WA: Is the brain ‘an immunologically privileged site’? (I) Studies based on intracerebral tumor homotransplantation and isotransplantation to sensitize hosts. Arch Neurol 11:248–264, 1964.
Morantz RA, Wood G: Adoptive intratumor immunotherapy of an experimental rat brain tumor. Presented at the meeting of the American Association of Neurological Surgeons, 1978.
Trouillas, P, Lapras CL: Immunotherapie active des tumeurs cerebrals. A propos de 20 cas. Neurochirurgie (Paris) 16:143–170, 1970.
Takakura K, Miki Y, Kulo O, Ogawa N, Matsutani M, Sana K: Adjuvant immunotherapy for malignant brain tumors. Jap J Clin Oncol 12:109–120, 1972.
Young HE, Kaplan A, Reglson W: Immunotherapy with autologous white cell infusion (‘lymphocytes’) in the treatment of recurrent glioblastoma multiforme. A prelimainary report. Cancer 40L:1037–1044, 1977.
Young HE, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976.
Ishizawa A: Immunotherapy for malignant gliomas. Neurol Med Chir (Tokyo) 21:179–191, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinbok, P., Thomas, J.P.W., Grossman, L. et al. Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. J Neuro-Oncol 2, 147–151 (1984). https://doi.org/10.1007/BF00177901
Issue Date:
DOI: https://doi.org/10.1007/BF00177901